Bristol Myers Squibb reported $-10027000000 in Net Income for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2162M 930M
Abbvie ABBV:US $ 36M 2272M
ALKERMES ALKS:US $ -42.64M 42.51M
Amgen AMGN:US $ 1615M 406M
AstraZeneca AZN:LN 1012M 364M
Astrazeneca AZN:US $ 1012M 364M
Biogen BIIB:US $ 357.9M 343.6M
Bristol Myers Squibb BMY:US $ -10027M 11899M
Catalent CTLT:US $ 88.4M 6M
Coherus Biosciences CHRS:US $ 9.71M 18.23M
Drreddys Laboratories RDY:US $ 198M 7425M
Eli Lilly And LLY:US $ 2116.8M 908.4M
Endo International Ordinary Shares ENDP:US $ 119.34M 195.23M
Gilead Sciences GILD:US $ 1551M 1191M
GlaxoSmithKline GSK:LN 677M 567M
Gw Pharmaceuticals GWPH:US $ -29.15M 16.96M
Horizon Pharma HZNP:US $ 190.56M 102.28M
Intercept Pharmaceuticals ICPT:US $ -52.15M 14.32M
JAZZ PHA JAZZ:US $ 133.41M 14.82M
Johnson & Johnson JNJ:US $ 1738M 1816M
Lannett LCI:US $ -171.95M 165.45M
Medtronic MDT:US $ 1270M 781M
Merk MRK:US $ -2094M 5035M
Novartis NOVN:VX SF 2094M 159M
Pfizer PFE:US $ 594M 1600M
Phibro Animal Health PAHC:US $ 12.8M 0.5M
Prestige Brands PBH:US $ 40.87M 3.72M
Regeneron Pharmaceuticals REGN:US $ 1149.2M 307.1M
Revance Therapeutics RVNC:US $ -78.31M 2.95M
Teva Pharmaceutical Industries TEVA:US $ 149M 4498M
United Therapeutics UTHR:US $ 98.8M 72.4M
Zoetis ZTS:US $ 359M 120M